Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 492

1.

Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.

Nakamizo A, Marini F, Amano T, Khan A, Studeny M, Gumin J, Chen J, Hentschel S, Vecil G, Dembinski J, Andreeff M, Lang FF.

Cancer Res. 2005 Apr 15;65(8):3307-18. Erratum in: Cancer Res. 2006 Jun 1;66(11):5975.

2.

Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy.

Menon LG, Kelly K, Yang HW, Kim SK, Black PM, Carroll RS.

Stem Cells. 2009 Sep;27(9):2320-30. doi: 10.1002/stem.136.

3.

Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.

Yang B, Wu X, Mao Y, Bao W, Gao L, Zhou P, Xie R, Zhou L, Zhu J.

Neurosurgery. 2009 Sep;65(3):610-24; discussion 624. doi: 10.1227/01.NEU.0000350227.61132.A7.

PMID:
19687708
4.

Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.

Kim SM, Lim JY, Park SI, Jeong CH, Oh JH, Jeong M, Oh W, Park SH, Sung YC, Jeun SS.

Cancer Res. 2008 Dec 1;68(23):9614-23. doi: 10.1158/0008-5472.CAN-08-0451.

5.

Platelet-derived growth factor BB mediates the tropism of human mesenchymal stem cells for malignant gliomas.

Hata N, Shinojima N, Gumin J, Yong R, Marini F, Andreeff M, Lang FF.

Neurosurgery. 2010 Jan;66(1):144-56; discussion 156-7. doi: 10.1227/01.NEU.0000363149.58885.2E.

6.

In vivo magnetic resonance imaging of cell tropism, trafficking mechanism, and therapeutic impact of human mesenchymal stem cells in a murine glioma model.

Chien LY, Hsiao JK, Hsu SC, Yao M, Lu CW, Liu HM, Chen YC, Yang CS, Huang DM.

Biomaterials. 2011 Apr;32(12):3275-84. doi: 10.1016/j.biomaterials.2011.01.042. Epub 2011 Feb 3.

PMID:
21295344
7.

Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma.

Sonabend AM, Ulasov IV, Tyler MA, Rivera AA, Mathis JM, Lesniak MS.

Stem Cells. 2008 Mar;26(3):831-41. doi: 10.1634/stemcells.2007-0758. Epub 2008 Jan 10.

8.

Effect of human skin-derived stem cells on vessel architecture, tumor growth, and tumor invasion in brain tumor animal models.

Pisati F, Belicchi M, Acerbi F, Marchesi C, Giussani C, Gavina M, Javerzat S, Hagedorn M, Carrabba G, Lucini V, Gaini SM, Bresolin N, Bello L, Bikfalvi A, Torrente Y.

Cancer Res. 2007 Apr 1;67(7):3054-63.

9.

Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression.

Kim SK, Kim SU, Park IH, Bang JH, Aboody KS, Wang KC, Cho BK, Kim M, Menon LG, Black PM, Carroll RS.

Clin Cancer Res. 2006 Sep 15;12(18):5550-6.

10.

Cytosine deaminase-producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model.

You MH, Kim WJ, Shim W, Lee SR, Lee G, Choi S, Kim DY, Kim YM, Kim H, Han SU.

J Gastroenterol Hepatol. 2009 Aug;24(8):1393-400. doi: 10.1111/j.1440-1746.2009.05862.x. Epub 2009 May 28.

PMID:
19486256
11.

Human mesenchymal stem cells overexpressing pigment epithelium-derived factor inhibit hepatocellular carcinoma in nude mice.

Gao Y, Yao A, Zhang W, Lu S, Yu Y, Deng L, Yin A, Xia Y, Sun B, Wang X.

Oncogene. 2010 May 13;29(19):2784-94. doi: 10.1038/onc.2010.38. Epub 2010 Mar 1.

PMID:
20190814
12.

Vascular endothelial growth factor A contributes to glioma-induced migration of human marrow stromal cells (hMSC).

Schichor C, Birnbaum T, Etminan N, Schnell O, Grau S, Miebach S, Aboody K, Padovan C, Straube A, Tonn JC, Goldbrunner R.

Exp Neurol. 2006 Jun;199(2):301-10. Epub 2006 Mar 29.

PMID:
16574102
13.

Local irradiation not only induces homing of human mesenchymal stem cells at exposed sites but promotes their widespread engraftment to multiple organs: a study of their quantitative distribution after irradiation damage.

François S, Bensidhoum M, Mouiseddine M, Mazurier C, Allenet B, Semont A, Frick J, Saché A, Bouchet S, Thierry D, Gourmelon P, Gorin NC, Chapel A.

Stem Cells. 2006 Apr;24(4):1020-9. Epub 2005 Dec 8.

14.

CXCR4-transfected human umbilical cord blood-derived mesenchymal stem cells exhibit enhanced migratory capacity toward gliomas.

Park SA, Ryu CH, Kim SM, Lim JY, Park SI, Jeong CH, Jun JA, Oh JH, Park SH, Oh W, Jeun SS.

Int J Oncol. 2011 Jan;38(1):97-103.

PMID:
21109930
15.

Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme.

Phuong LK, Allen C, Peng KW, Giannini C, Greiner S, TenEyck CJ, Mishra PK, Macura SI, Russell SJ, Galanis EC.

Cancer Res. 2003 May 15;63(10):2462-9.

16.

Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development.

Hong YK, Chung DS, Joe YA, Yang YJ, Kim KM, Park YS, Yung WK, Kang JK.

Clin Cancer Res. 2000 Aug;6(8):3354-60.

17.

Targeting rat brainstem glioma using human neural stem cells and human mesenchymal stem cells.

Lee DH, Ahn Y, Kim SU, Wang KC, Cho BK, Phi JH, Park IH, Black PM, Carroll RS, Lee J, Kim SK.

Clin Cancer Res. 2009 Aug 1;15(15):4925-34. doi: 10.1158/1078-0432.CCR-08-3076. Epub 2009 Jul 28. Erratum in: Clin Cancer Res. 2010 Nov 1;16(21):5367.

18.

Human bone marrow-derived mesenchymal stem cells for intravascular delivery of oncolytic adenovirus Delta24-RGD to human gliomas.

Yong RL, Shinojima N, Fueyo J, Gumin J, Vecil GG, Marini FC, Bogler O, Andreeff M, Lang FF.

Cancer Res. 2009 Dec 1;69(23):8932-40. doi: 10.1158/0008-5472.CAN-08-3873. Epub 2009 Nov 17.

19.

Homing properties of adipose-derived stem cells to intracerebral glioma and the effects of adenovirus infection.

Lamfers M, Idema S, van Milligen F, Schouten T, van der Valk P, Vandertop P, Dirven C, Noske D.

Cancer Lett. 2009 Feb 8;274(1):78-87. doi: 10.1016/j.canlet.2008.08.035. Epub 2008 Oct 7.

PMID:
18842332
20.

Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents.

Studeny M, Marini FC, Dembinski JL, Zompetta C, Cabreira-Hansen M, Bekele BN, Champlin RE, Andreeff M.

J Natl Cancer Inst. 2004 Nov 3;96(21):1593-603.

PMID:
15523088

Supplemental Content

Support Center